Rani Therapeutics (RANI) Institutional Ownership $2.02 -0.03 (-1.46%) (As of 11:20 AM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Rani Therapeutics (NASDAQ:RANI)CurrentInstitutional OwnershipPercentage30.19%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$525.89KNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$940.82K Get RANI Insider Trade Alerts Want to know when executives and insiders are buying or selling Rani Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RANI Institutional Buying and Selling by Quarter Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Rani Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC172,261$372K0.0%+14.3%0.323% 11/15/2024 United Services Automobile Association302,743$654K0.0%-3.0%0.567% 11/15/2024 Stifel Financial Corp269,768$583K0.0%+100.4%0.505% 11/8/2024 King Luther Capital Management Corp81,129$175K0.0%+44.5%0.152% 8/14/2024 Marshall Wace LLP21,247$81K0.0%N/A0.042% 8/9/2024 Renaissance Technologies LLC21,700$82K0.0%-69.1%0.043% Get the Latest News and Ratings for RANI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rani Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/7/2024 United Services Automobile Association312,095$1.19M0.0%-35.2%0.619% 5/10/2024 Vanguard Group Inc.685,303$2.13M0.0%+2.5%1.366% 2/14/2024 Alpha Square Group S LLC58,946$196K0.2%-32.2%0.118% 8/10/2023 King Luther Capital Management Corp56,129$231K0.0%N/A0.113% 8/4/2023 Choreo LLC19,813$82K0.0%-20.2%0.040% 5/11/2023Icon Wealth Partners LLC12,757$66K0.0%N/A0.026% 5/11/2023 Alphabet Inc.448,492$2.31M0.1%-12.1%0.908% 2/8/2023 Prime Capital Investment Advisors LLC33,502$198K0.0%N/A0.068% 11/18/2022TPB Wealth Advisors48,129$461K0.2%-33.0%0.098% 11/16/2022 Alphabet Inc.714,471$6.85M0.3%N/A1.453% 11/3/2022 Motco48,129$461K0.0%N/A0.098% 10/28/2022 Lafayette Investments Inc.19,893$191K0.1%N/A0.040% 10/17/2022 Canton Hathaway LLC16,200$155K0.1%+88.4%0.033% 10/14/2022 Iowa State Bank18,862$181K0.1%N/A0.038% 8/8/2022 Islay Capital Management LLC9,611$99K0.1%N/A0.020% 8/8/2022Crossvault Capital Management LLC14,285$148K0.1%N/A0.029% 7/29/2022Aspireon Wealth Advisors71,811$742K0.3%N/A0.146% 7/20/2022 Canton Hathaway LLC8,600$89K0.0%N/A0.017% 6/15/2022 Lasry Marc62,828$848K0.4%N/A0.128% 5/17/2022 Lasry Marc62,828$848K0.4%N/A0.128% 5/13/2022 United Services Automobile Association481,300$6.50M0.1%N/A0.979% 2/3/2022 Advisor Group Holdings Inc.21,072$344K0.0%N/A0.043% 1/6/2022 Canton Hathaway LLC5,000$82K0.0%-50.0%0.010% 11/16/2021 Squarepoint Ops LLC50,000$891K0.0%N/A0.102% 11/15/2021 Caas Capital Management LP75,000$1.34M0.0%N/A0.153% 11/10/2021 Goldman Sachs Group Inc.60,649$1.08M0.0%N/A0.124% (Data available from 1/1/2016 forward) RANI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RANI shares? During the previous two years, 12 institutional investors and hedge funds held shares of Rani Therapeutics. The most heavily invested institutionals were Alphabet Inc. ($2.31M), Vanguard Group Inc. ($2.13M), United Services Automobile Association ($654K), Stifel Financial Corp ($583K), Geode Capital Management LLC ($372K), Prime Capital Investment Advisors LLC ($198K), and Alpha Square Group S LLC ($196K).Learn more on RANI's institutional investors. What percentage of Rani Therapeutics stock is owned by institutional investors? 30.19% of Rani Therapeutics stock is owned by institutional investors. Learn more on RANI's institutional investor holdings. Which institutional investors have been buying Rani Therapeutics stock? The following institutional investors have purchased Rani Therapeutics stock in the last 24 months: Stifel Financial Corp ($135.15K), King Luther Capital Management Corp ($81.13K), Prime Capital Investment Advisors LLC ($33.50K), Geode Capital Management LLC ($21.53K), Marshall Wace LLP ($21.25K), Vanguard Group Inc. ($16.96K), and Icon Wealth Partners LLC ($12.76K). How much institutional buying is happening at Rani Therapeutics? Institutional investors have bought a total of 322,266 shares in the last 24 months. This purchase volume represents approximately $1.02M in transactions. Which Rani Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Rani Therapeutics stock in the last 24 months: United Services Automobile Association ($178.56K), Alphabet Inc. ($61.64K), Renaissance Technologies LLC ($48.60K), Alpha Square Group S LLC ($28K), and Choreo LLC ($5K). How much institutional selling is happening at Rani Therapeutics? Institutional investors have sold a total of 321,793 shares in the last 24 months. This volume of shares sold represents approximately $1.28M in transactions. Related Companies PYXS Major Shareholders PASG Major Shareholders RNAC Major Shareholders TNGX Major Shareholders CGC Major Shareholders AQST Major Shareholders TSHA Major Shareholders TKNO Major Shareholders AKBA Major Shareholders KALV Major Shareholders This page (NASDAQ:RANI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rani Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rani Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
